Cargando…

Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?

PURPOSE: The intensity of prostate-specific membrane antigen (PSMA) expression increases as the tumor grade increases and the uptake of Ga-68-PSMA is higher in high-grade tumors. The aim of the present study was to evaluate the correlation of preoperative tracer uptake of primary tumor to Gleason Sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirci, Emre, Kabasakal, Levent, Şahin, Onur E., Akgün, Elife, Gültekin, Mehmet Hamza, Doğanca, Tünkut, Tuna, Mustafa B., Öbek, Can, Kiliç, Mert, Esen, Tarik, Kural, Ali R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282663/
https://www.ncbi.nlm.nih.gov/pubmed/30395048
http://dx.doi.org/10.1097/MNM.0000000000000942
_version_ 1783379042643214336
author Demirci, Emre
Kabasakal, Levent
Şahin, Onur E.
Akgün, Elife
Gültekin, Mehmet Hamza
Doğanca, Tünkut
Tuna, Mustafa B.
Öbek, Can
Kiliç, Mert
Esen, Tarik
Kural, Ali R.
author_facet Demirci, Emre
Kabasakal, Levent
Şahin, Onur E.
Akgün, Elife
Gültekin, Mehmet Hamza
Doğanca, Tünkut
Tuna, Mustafa B.
Öbek, Can
Kiliç, Mert
Esen, Tarik
Kural, Ali R.
author_sort Demirci, Emre
collection PubMed
description PURPOSE: The intensity of prostate-specific membrane antigen (PSMA) expression increases as the tumor grade increases and the uptake of Ga-68-PSMA is higher in high-grade tumors. The aim of the present study was to evaluate the correlation of preoperative tracer uptake of primary tumor to Gleason Score in patients who underwent prostatectomy. PATIENTS AND METHODS: We retrospectively evaluated 141 patients who had Ga-68-PSMA positron emission tomography/computed tomography (PET/CT) imaging and who underwent prostatectomy. All patients had a diagnosis of prostate cancer on the basis of 10–24 cores transrectal ultrasound-guided biopsy (TRUS-Bx). Histological assessment was performed according to the New Contemporary Prostate Cancer Grading System. All patients had a prostate-specific antigen (PSA) level measurement within maximum of 28 days before Ga-68-PSMA PET/CT. Region of interests were drawn manually around the prostate gland, avoiding the bladder activity, to calculate the maximum standardized uptake values (SUVmax) values. RESULTS: The median PSA values for all patients were 10.0 ng/ml. PSA values for low-risk patients were significantly lower than those of high-risk patients (P<0.001). There were 41.1% upgrades and 7.8% downgrades following prostatectomy in terms of Grade Groups. According to the final pathology reports, 21% (n=16) of patients moved from a low-risk level (grade groups 1+2) to a high-risk level (grade groups 3+4+5). The median SUVmax value was 8.8, ranging from 2.1 to 62.4. There was a strong correlation between SUVmax values and grade groups (Pearson ρ=0.66) (P<0.001). The mean SUVmax values of high-risk patients were significantly higher than those of low-risk patients (18.9±12.1 vs. 7.16±6.2, respectively) (P<0.001). Receiver operation characteristic curve analysis of SUVmax at the cut-off value of 9.1 showed a high sensitivity (78%) and specificity (81%) for detection of high risk disease. CONCLUSION: SUVmax values correlate significantly with the grade groups of the primary tumor. The intraprostatic accumulation sites may predict clinically significant cancer and potentially serve as a target for biopsy sampling in conjunction with mpMRI in selected patients.
format Online
Article
Text
id pubmed-6282663
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-62826632019-01-14 Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer? Demirci, Emre Kabasakal, Levent Şahin, Onur E. Akgün, Elife Gültekin, Mehmet Hamza Doğanca, Tünkut Tuna, Mustafa B. Öbek, Can Kiliç, Mert Esen, Tarik Kural, Ali R. Nucl Med Commun Original Articles PURPOSE: The intensity of prostate-specific membrane antigen (PSMA) expression increases as the tumor grade increases and the uptake of Ga-68-PSMA is higher in high-grade tumors. The aim of the present study was to evaluate the correlation of preoperative tracer uptake of primary tumor to Gleason Score in patients who underwent prostatectomy. PATIENTS AND METHODS: We retrospectively evaluated 141 patients who had Ga-68-PSMA positron emission tomography/computed tomography (PET/CT) imaging and who underwent prostatectomy. All patients had a diagnosis of prostate cancer on the basis of 10–24 cores transrectal ultrasound-guided biopsy (TRUS-Bx). Histological assessment was performed according to the New Contemporary Prostate Cancer Grading System. All patients had a prostate-specific antigen (PSA) level measurement within maximum of 28 days before Ga-68-PSMA PET/CT. Region of interests were drawn manually around the prostate gland, avoiding the bladder activity, to calculate the maximum standardized uptake values (SUVmax) values. RESULTS: The median PSA values for all patients were 10.0 ng/ml. PSA values for low-risk patients were significantly lower than those of high-risk patients (P<0.001). There were 41.1% upgrades and 7.8% downgrades following prostatectomy in terms of Grade Groups. According to the final pathology reports, 21% (n=16) of patients moved from a low-risk level (grade groups 1+2) to a high-risk level (grade groups 3+4+5). The median SUVmax value was 8.8, ranging from 2.1 to 62.4. There was a strong correlation between SUVmax values and grade groups (Pearson ρ=0.66) (P<0.001). The mean SUVmax values of high-risk patients were significantly higher than those of low-risk patients (18.9±12.1 vs. 7.16±6.2, respectively) (P<0.001). Receiver operation characteristic curve analysis of SUVmax at the cut-off value of 9.1 showed a high sensitivity (78%) and specificity (81%) for detection of high risk disease. CONCLUSION: SUVmax values correlate significantly with the grade groups of the primary tumor. The intraprostatic accumulation sites may predict clinically significant cancer and potentially serve as a target for biopsy sampling in conjunction with mpMRI in selected patients. Lippincott Williams & Wilkins 2019-01 2018-10-26 /pmc/articles/PMC6282663/ /pubmed/30395048 http://dx.doi.org/10.1097/MNM.0000000000000942 Text en Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
spellingShingle Original Articles
Demirci, Emre
Kabasakal, Levent
Şahin, Onur E.
Akgün, Elife
Gültekin, Mehmet Hamza
Doğanca, Tünkut
Tuna, Mustafa B.
Öbek, Can
Kiliç, Mert
Esen, Tarik
Kural, Ali R.
Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
title Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
title_full Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
title_fullStr Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
title_full_unstemmed Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
title_short Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
title_sort can suvmax values of ga-68-psma pet/ct scan predict the clinically significant prostate cancer?
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282663/
https://www.ncbi.nlm.nih.gov/pubmed/30395048
http://dx.doi.org/10.1097/MNM.0000000000000942
work_keys_str_mv AT demirciemre cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer
AT kabasakallevent cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer
AT sahinonure cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer
AT akgunelife cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer
AT gultekinmehmethamza cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer
AT dogancatunkut cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer
AT tunamustafab cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer
AT obekcan cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer
AT kilicmert cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer
AT esentarik cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer
AT kuralalir cansuvmaxvaluesofga68psmapetctscanpredicttheclinicallysignificantprostatecancer